Back to Search Start Over

Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccine

Authors :
Slim Fourati
Susan Pereira Ribeiro
Filipa Blasco Tavares Pereira Lopes
Aarthi Talla
Francois Lefebvre
Mark Cameron
J. Kaewkungwal
P. Pitisuttithum
S. Nitayaphan
S. Rerks-Ngarm
Jerome H. Kim
Rasmi Thomas
Peter B. Gilbert
Georgia D. Tomaras
Richard A. Koup
Nelson L. Michael
M. Juliana McElrath
Raphael Gottardo
Rafick-Pierre Sékaly
Source :
Nature Communications, Vol 10, Iss 1, Pp 1-12 (2019)
Publication Year :
2019
Publisher :
Nature Portfolio, 2019.

Abstract

The RV144 vaccine trial showed reduced risk of HIV-1 acquisition, but mechanisms underlying protection are poorly understood. Here, Fourati et al. assess the transcriptomic profile of blood collected from 223 vaccinees and 40 placebo recipients and identify IRF7 as a mediator of protection.

Subjects

Subjects :
Science

Details

Language :
English
ISSN :
20411723
Volume :
10
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Nature Communications
Publication Type :
Academic Journal
Accession number :
edsdoj.39e0d85840e44cd7872a97b96a0ffad9
Document Type :
article
Full Text :
https://doi.org/10.1038/s41467-019-08854-2